BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37907775)

  • 1. Drug Utilisation Patterns of Alternatives to Ranitidine-Containing Medicines in Patients Treated with Ranitidine: A Network Analysis of Data from Six European National Databases.
    Arinze JT; de Ridder MAJ; Vojinovic D; van Ballegooijen H; Markov E; Duarte-Salles T; Rijnbeek P; Verhamme KMC
    Drug Saf; 2023 Dec; 46(12):1353-1362. PubMed ID: 37907775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription changes in patients with gastrointestinal disorders after withdrawal of ranitidine: a nationwide population-based cohort study.
    Ku M; Je NK
    Curr Med Res Opin; 2023 Feb; 39(2):197-203. PubMed ID: 36519289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranitidine Use and Incident Cancer in a Multinational Cohort.
    You SC; Seo SI; Falconer T; Yanover C; Duarte-Salles T; Seager S; Posada JD; Shah NH; Nguyen PA; Kim Y; Hsu JC; Van Zandt M; Hsu MH; Lee HL; Ko H; Shin WG; Pratt N; Park RW; Reich CG; Suchard MA; Hripcsak G; Park CH; Prieto-Alhambra D
    JAMA Netw Open; 2023 Sep; 6(9):e2333495. PubMed ID: 37725377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
    Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
    Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists.
    Houben E; Johansson S; Nagy P; Penning-van Beest FJA; Kuipers EJ; Herings RMC
    Curr Med Res Opin; 2018 Apr; 34(4):577-583. PubMed ID: 29149805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major Shifts in Acid Suppression Drug Utilization After the 2019 Ranitidine Recalls in Canada and United States.
    Gunning R; Chu C; Nakhla N; Kim KC; Suda KJ; Tadrous M
    Dig Dis Sci; 2023 Aug; 68(8):3259-3267. PubMed ID: 37269368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
    Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.
    Zhu LL; Xu LC; Chen Y; Zhou Q; Zeng S
    World J Gastroenterol; 2012 Jun; 18(24):3167-72. PubMed ID: 22791953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranitidine and Risk of Bladder and Kidney Cancer: A Population-Based Cohort Study.
    Nørgaard M; Andersen IT; Heide-Jørgensen U; Erichsen R; Rees JR; Karagas MR; Sørensen HT
    Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):45-50. PubMed ID: 34649959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke.
    Momosaki R; Yasunaga H; Matsui H; Fushimi K; Abo M
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1035-1040. PubMed ID: 26853142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between ranitidine use with potential NDMA impurities and risk of cancer in Korea.
    Joung KI; Hwang JE; Oh IS; Cho SI; Shin JY
    Sci Rep; 2022 Dec; 12(1):22396. PubMed ID: 36575247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consumption of medicines used for gastric acid-related disorders in Australia and South Korea: a cross-country comparison.
    Yu SY; Lee B; McGuire TM; Lee HJ; Hollingworth SA
    Eur J Clin Pharmacol; 2020 Apr; 76(4):547-555. PubMed ID: 31822956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosage effects of histamine-2 receptor antagonist on the primary prophylaxis of non-steroidal anti-inflammatory drug (NSAID)-associated peptic ulcers: a retrospective cohort study.
    He Y; Chan EW; Man KK; Lau WC; Leung WK; Ho LM; Wong IC
    Drug Saf; 2014 Sep; 37(9):711-21. PubMed ID: 25096957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranitidine-induced anaphylaxis: clinical features, cross-reactivity, and skin testing.
    Park KH; Pai J; Song DG; Sim DW; Park HJ; Lee JH; Jeong KY; Pan CH; Shin I; Park JW
    Clin Exp Allergy; 2016 Apr; 46(4):631-9. PubMed ID: 26764898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs.
    Sturkenboom MC; Burke TA; Tangelder MJ; Dieleman JP; Walton S; Goldstein JL
    Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1137-47. PubMed ID: 14653834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with proton pump inhibitors induces tolerance to histamine-2 receptor antagonists in Helicobacter pylori-negative patients.
    Qvigstad G; Arnestad JS; Brenna E; Waldum HL
    Scand J Gastroenterol; 1998 Dec; 33(12):1244-8. PubMed ID: 9930386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranitidine Use and Risk of Upper Gastrointestinal Cancers.
    Adami HO; Trolle Andersen I; Heide-Jørgensen U; Chang ET; Nørgaard M; Sørensen HT
    Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2302-2308. PubMed ID: 34620629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.